|
|
|
|
|
20.12.25 - 09:42
|
Nach dem Kurssturz: Der Rettungsplan für Novo Nordisk (Manager-Magazin)
|
|
|
Dank der Abnehmspritze Wegovy stieg der dänische Pharmakonzern Novo Nordisk fast über Nacht zum wertvollsten Konzern Europas auf. Dann folgte der Absturz. Wie Ex-Champion Novo jetzt an seinem Comeback arbeitet und den US-Konkurrenten Eli Lilly wieder einholen will....
|
|
|
|
|
20.12.25 - 07:15
|
Novo Nordisk-Aktie: Kann das die Trendwende bringen? (Sharedeals)
|
|
|
Die Novo Nordisk-Aktie hat sich in den letzten Wochen knapp über der Marke von 40 € stabilisiert. Eine Trendwende nach oben zeichnet sich allerdings noch nicht ab. Könnte diese neue Nachricht dem dänischen Pharmakonzern neuen Schwung verleihen und sollten Anleger jetzt endlich auf die Aktie setzen? Eine neue Adipositas-Zulassung Es ist endlich mal wieder eine richtig […]
The post Novo Nordisk-Aktie: Kann das die Trendwende bringen? first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
19.12.25 - 15:55
|
Advanced discussions to obtain equity line financing from IRIS Capital Investment (Cision)
|
|
|
This announcement contains inside information
Company Announcement No. 35-25
Copenhagen, 19 December 2025
Shape Robotics A/S (“Shape Robotics” or the “Company”) announces that it is in the advanced stages of closing and entering into an equity line financing arrangement with IRIS Capital Investment, a French investment company active in the market for the better part of the past 15 years. To this end, the Company has received a non-binding offer providing the following essential terms:
The envisioned financing agreement would provide for a convertible loan to be made available to...
|
|
|
19.12.25 - 15:55
|
Change of Shape Robotics A/S Auditor (Cision)
|
|
|
This announcement contains inside information
Company Announcement No. 36-25
Copenhagen, 19 December 2025
Shape Robotics A/S (“Shape Robotics” or the “Company”) announces that its relationship with Beierholm, Statsautoriseret Revisionspartnerselskab („Beierholm”), in its capacity as state-authorized auditor for the Company, has come to a close. The Company is currently in talks with other audit service providers, with the goal of appointing an auditor which also features a more international scope in its presence and activities, so as to more easily ensure group-level synergy with...
|
|
|
|
|
|
|
|
|
19.12.25 - 13:18
|
Vestas announces new order for 205 MW in Australia (Cision)
|
|
|
News release from Vestas Asia Pacific
Seoul, 19 December 2025
Vestas is proud to announce the following order as part of our Q4 order intake:
Country Region Customer Project MW Turbine Service Delivery &
name variant agreement commissioning
Australia APAC Undisclosed Undisclosed 205 33 x 30-years Delivery and
V162 AOM 5000 Commissioning
-6.2 Service in...
|
|
|
|
|
|
|
19.12.25 - 11:46
|
Novo Nordisk: Wichtiger Schritt (Der Aktionaer)
|
|
|
Die Aktie von Novo Nordisk verharrt derzeit im Bereich der Marke von 300 dänischen Kronen. Auch die jüngste Meldung, dass das Unternehmen in den USA den Zulassungsantrag für CagriSema-Injektionen – Verabreichung einmal wöchentlich – gestellt hat, konnte keinen neuen Schwung bringen....
|
|
|
|
|
|
|
|
|
19.12.25 - 10:01
|
Dampskibsselskabet NORDEN A/S – weekly report on share buy-back (Cision)
|
|
|
ANNOUNCEMENT NO. 269 – 19 DECEMBER 2025
On 31 October 2025, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 31 October 2025 up to and including no later than 29 January 2026. For details, please see announcement no. 227 of 30 October 2025.
Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 10 million (approximately DKK 64...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
